Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 5
1952 3
1955 1
1956 1
1960 3
1962 1
1963 2
1964 2
1965 3
1967 2
1968 5
1969 1
1970 1
1971 2
1972 4
1973 6
1974 2
1975 2
1976 5
1977 4
1978 3
1979 4
1980 1
1981 5
1982 2
1983 2
1984 3
1985 2
1986 1
1987 5
1988 3
1989 4
1990 3
1991 1
1993 1
1994 2
1995 2
1996 1
1997 2
1998 2
1999 3
2000 2
2001 3
2002 1
2003 3
2004 1
2005 1
2006 1
2009 1
2010 1
2011 1
2012 3
2013 7
2014 2
2015 1
2016 3
2017 1
2018 1
2019 4
2020 1
2021 2
2022 4
2023 8
2024 7
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for archer v
Search for Arcier V instead (1 results)
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.
West H, McCleod M, Hussein M, Morabito A, Rittmeyer A, Conter HJ, Kopp HG, Daniel D, McCune S, Mekhail T, Zer A, Reinmuth N, Sadiq A, Sandler A, Lin W, Ochi Lohmann T, Archer V, Wang L, Kowanetz M, Cappuzzo F. West H, et al. Among authors: archer v. Lancet Oncol. 2019 Jul;20(7):924-937. doi: 10.1016/S1470-2045(19)30167-6. Epub 2019 May 20. Lancet Oncol. 2019. PMID: 31122901 Clinical Trial.
2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Brière R, Émond M, Benhamed A, Blanchard PG, Drolet S, Habashi R, Golbon B, Shellenberger J, Pasternak J, Merchant S, Shellenberger J, La J, Sawhney M, Brogly S, Cadili L, Horkoff M, Ainslie S, Demetrick J, Chai B, Wiseman K, Hwang H, Alhumoud Z, Salem A, Lau R, Aw K, Nessim C, Gawad N, Alibhai K, Towaij C, Doan D, Raîche I, Valji R, Turner S, Balmes PN, Hwang H, Hameed SM, Tan JGK, Wijesuriya R, Tan JGK, Hew NLC, Wijesuriya R, Lund M, Hawel J, Gregor J, Leslie K, Lenet T, McIsaac D, Hallet J, Jerath A, Lalu M, Nicholls S, Presseau J, Tinmouth A, Verret M, Wherrett C, Fergusson D, Martel G, Sharma S, McKechnie T, Talwar G, Patel J, Heimann L, Doumouras A, Hong D, Eskicioglu C, Wang C, Guo M, Huang L, Sun S, Davis N, Wang J, Skulsky S, Sikora L, Raîche I, Son HJ, Gee D, Gomez D, Jung J, Selvam R, Seguin N, Zhang L, Lacaille-Ranger A, Sikora L, McIsaac D, Moloo H, Follett A, Holly, Organ M, Pace D, Balvardi S, Kaneva P, Semsar-Kazerooni K, Mueller C, Vassiliou M, Al Mahroos M, Fiore JF Jr, Schwartzman K, Feldman L, Guo M, Karimuddin A, Liu GP, Crump T, Sutherland J, Hickey K, Bonisteel EM, Umali J, Dogar I, Warden G, Boone D, Mathieson A, Hogan M, Pace D, Seguin N, Moloo H, Li Y, Be… See abstract for full author list ➔ Brière R, et al. Among authors: archer v. Can J Surg. 2023 Dec 13;66(6 Suppl 1):S54-S136. doi: 10.1503/cjs.014223. Print 2023 Nov-Dec. Can J Surg. 2023. PMID: 38173057 Free PMC article. No abstract available.
Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial.
Peters S, Gadgeel SM, Mok T, Nadal E, Kilickap S, Swalduz A, Cadranel J, Sugawara S, Chiu CH, Yu CJ, Moskovitz M, Tanaka T, Nersesian R, Shagan SM, Maclennan M, Mathisen M, Bhagawati-Prasad V, Diarra C, Assaf ZJ, Archer V, Dziadziuszko R. Peters S, et al. Among authors: archer v. Nat Med. 2024 Jul;30(7):1923-1932. doi: 10.1038/s41591-024-03008-4. Epub 2024 Jun 19. Nat Med. 2024. PMID: 38898120 Free PMC article. Clinical Trial.
2024 Canadian Surgery Forum: Sept. 25-28, 2024.
Li C, Guo M, Karimuddin A, Guo M, Li C, Karimuddin A, Sutherland J, Huo B, McKechnie T, Ortenzi M, Lee Y, Antoniou S, Mayol J, Ahmed H, Boudreau V, Ramji K, Eskicioglu C, de Jager P, Urbach D, Poole M, Abbad A, Al-Shamali H, Al-Faraj Z, Wen C, Pescarus R, Bechara R, Hong D, Park LJ, Marcucci M, Ofori S, Bogach J, Serrano PE, Simunovic M, Yang I, Cadeddu M, Marcaccio MJ, Borges FK, Nenshi R, Devereaux PJ, Urbanellis P, Douglas J, Nemeth E, Ellsmere J, Spence R, Cunningham J, Falk R, Skinner T, Ebert N, Galbraith L, Prins M, Joharifard S, Joos E, Orovec A, Lethbridge L, Spence R, Hoogerboord M, Stuart H, Bergeron AM, Yang I, Bogach J, Nguyen L, Reade C, Eiriksson L, Morais M, Hanley G, Mah S, Brar K, Seymour KA, Eckhouse SR, Sudan R, Greenberg JA, Portenier D, Jung JJ, Light A, Dingley B, Delisle M, Apte S, Mallick R, Hamilton T, Stuart H, Talbot M, McKinnon G, Jost E, Thiboutot E, Nessim C, Katote N, Drohan A, Spence R, Neumann K, Shi G, Leung R, Lim C, Van Oirschot M, Grant A, Knowles S, Van Koughnett JA, Brousseau K, Monette L, McIsaac D, Wherrett C, Mallick R, Workneh A, Ramsay T, Tinmouth A, Shaw J, Carrier FM, Fergusson D, Martel G, Cornacchia M, Ivankovic V, Mamalchi SA, Choi… See abstract for full author list ➔ Li C, et al. Among authors: archer v. Can J Surg. 2024 Nov 28;67(6suppl2):S77-S108. doi: 10.1503/cjs.012624. Print 2024 Nov-Dec. Can J Surg. 2024. PMID: 39609036 Free PMC article. No abstract available.
Alectinib Versus Crizotinib in Asian Patients With Treatment-Naïve Advanced ALK-Positive NSCLC: Five-Year Update From the Phase 3 ALESIA Study.
Zhou C, Lu Y, Kim SW, Reungwetwattana T, Zhou J, Zhang Y, He J, Yang JJ, Cheng Y, Lee SH, Chang J, Fang J, Liu Z, Bu L, Qian L, Xu T, Archer V, Hilton M, Zhou M, Zhang L. Zhou C, et al. Among authors: archer v. JTO Clin Res Rep. 2024 Jun 27;5(9):100700. doi: 10.1016/j.jtocrr.2024.100700. eCollection 2024 Sep. JTO Clin Res Rep. 2024. PMID: 39282663 Free PMC article.
163 results